1 / 5

OPTN/UNOS Histocompatibility Committee Report to the Board of Directors June 25-26, 2012

OPTN/UNOS Histocompatibility Committee Report to the Board of Directors June 25-26, 2012. Nancy L. Reinsmoen, PhD, Chair. 2011-2012 Committee Work. Recommended technical revisions to UNOS Bylaws Appendix C (Membership Requirement for Histocompatibility Laboratories)

dutch
Télécharger la présentation

OPTN/UNOS Histocompatibility Committee Report to the Board of Directors June 25-26, 2012

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. OPTN/UNOS Histocompatibility CommitteeReport to the Board of DirectorsJune 25-26, 2012 Nancy L. Reinsmoen, PhD, Chair

  2. 2011-2012 Committee Work • Recommended technical revisions to UNOS Bylaws Appendix C (Membership Requirement for Histocompatibility Laboratories) • Developed proposal on updating CPRA • Monitored use of CPRA in the transplant community • Monitored changes resulting from March 2011 update to Appendix 3A Collaboration with other Committees: • Kidney Committee--new kidney allocation system • Pediatric Committee--improving regional sharing for highly sensitized pediatric patients • KPD Workgroup--advising on KPD policy proposal and KPD program operations

  3. 2011-2012 Work Cont. Committee’s work has been/will be presented at several conferences this year: • ATC– Smoothing it Out:  Creating a Sliding Scale for Assigning CPRA-Based Allocation Points--Stewart, D.E., Kucheryavaya, A.Y., Reinsmoen, N.L., Friedewald, J.J. • TTS – Two Year Impact of Calculated PRA (CPRA) on Increasing Transplantation of Sensitized Patients --Reinsmoen, N.L., Baxter-Lowe, L.A., Cecka, J.M., Leffell, M.S., Gore, L.A., Kucheryavaya, A.Y. • ASHI – Centers With a Very Low Percentage of Broadly Sensitized Candidates Can Have a Negative Impact On the Efficiency of Kidney Allocation --Kucheryavaya, A.Y., Reinsmoen, N.L., Baxter-Lowe, L.A., Cecka, J.M. 

  4. 2012-2013 Committee Projects • Substantive Bylaws Rewrite • Updates to Appendix 3A • Addition of DPB and DQA to Waitlist and DonorNet • Continue to monitor use of CPRA in transplant community • Continue to monitor proposal for new kidney allocation system • Continue to monitor KPD

  5. Histocompatibility Bylaws Rewrite • Bylaws governing histocompatibility laboratories are antiquated and need to better reflect current laboratory practices • Conduct crosswalk between ASHI, CAP, and OPTN/UNOS standards/requirements to consider any conflicts • Committee will consider key issues: • Laboratory Directors: Credentialing and Supervision Requirements • Outcome/Performance Measures for Laboratories

More Related